[Therapy of pyelonephritis].
D000583:Amikacin / Q000627:therapeutic use; D000658:Amoxicillin / Q000627:therapeutic use; D000667:Ampicillin / Q000031:analogs & derivatives / Q000627:therapeutic use; D002228:Carbenicillin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D009268:Nalidixic Acid / Q000627:therapeutic use; D010403:Penicillin Resistance; D010917:Pivampicillin / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy / Q000628:therapy*; D013449:Sulfonamides / Q000627:therapeutic use; D013754:Tetracyclines / Q000627:therapeutic use; D014031:Tobramycin / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D002511:Cephalosporins; D005839:Gentamicins; D013449:Sulfonamides; D013754:Tetracyclines; D010917:Pivampicillin; D009268:Nalidixic Acid; D002701:Chloramphenicol; D000667:Ampicillin; D000658:Amoxicillin; D000583:Amikacin; D014295:Trimethoprim; D002228:Carbenicillin; D014031:Tobramycin
Die Therapie der Pyelonephritis.